DexCom, Inc.

NASDAQ:DXCM

71.92 (USD) • At close September 19, 2024
Bedrijfsnaam DexCom, Inc.
Symbool DXCM
Munteenheid USD
Prijs 71.92
Beurswaarde 28,820,285,840
Dividendpercentage 0%
52-weken bereik 62.34 - 142
Industrie Medical Devices
Sector Healthcare
CEO Mr. Kevin Ronald Sayer
Website https://www.dexcom.com

An error occurred while fetching data.

Over DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an

Vergelijkbare Aandelen

Biogen Inc. logo

Biogen Inc.

BIIB

201.44 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

517.06 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

27.99 USD

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

8.98 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

257.17 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

134.39 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)